Eyam

Eyam Health is a preclinical-stage Canadian biotechnology company developing next-generation nucleic acid medicines. Its proprietary Gemini platform enables carrier-free, long-acting biologic expression from a single intramuscular injection, while its AI-driven Jennerator engine optimizes nucleic acid sequences — positioning Eyam to accelerate the future of nucleic acid medicines.